Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
VTSI VirTra Inc
ALHC Alignment Healthcare Inc
PRGS Progress Software Corp
PMD Psychemedics Corp
RPHM Reneo Pharmaceuticals Inc
DFSU Dimensional US Sustainability Core 1 ETF
UNH UnitedHealth Group Inc
GURE Gulf Resources Inc
TDCX TDCX Inc
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. The Company also provides Expresse service assurance and CloudCheck WiFi experience management solutions.

Closing Price
$821.67
Day's Change
10.17 (1.25%)
Bid
--
Ask
--
B/A Size
--
Day's High
822.52
Day's Low
810.95
Volume
(Above Average)
Volume:
866,170

10-day average volume:
765,078
866,170
  • Prev Close
    811.50
  • Today's Open
    814.90
  • Day's Range
    810.95-822.52
  • Avg Vol (10-day)
    765.1K
  • Last (time)
    3:59p ET 03/31/23
  • Last (size)
    1
  • 52-Wk Range
    538.01 - 835.00
    LowHigh
  • (06/14/22 - 03/29/23)
    1.60%
  • 34.0%
  • Market Cap
    89.8B
  • Shares Outstanding
    109.3M
  • 38.24
  • 21.49x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 88.11
  • (% of float 03/15/23)
    1.16

Latest News

March 31, 2023
5:25 pm ET
MarketWatch
5:15 pm ET
Zacks
March 30, 2023
5:20 pm ET
MarketWatch
March 29, 2023
5:21 pm ET
MarketWatch
7:00 am ET
Globe Newswire
March 28, 2023
5:21 pm ET
MarketWatch
7:30 am ET
BusinessWire
7:30 am ET
Globe Newswire
March 27, 2023
5:20 pm ET
MarketWatch
March 24, 2023
5:20 pm ET
MarketWatch
6:19 am ET
MarketWatch
March 23, 2023
5:21 pm ET
MarketWatch
1:56 pm ET
MarketWatch
10:11 am ET
PR Newswire
7:57 am ET
MarketWatch
2:00 am ET
Globe Newswire
2:00 am ET
Globe Newswire
March 22, 2023
5:21 pm ET
MarketWatch
7:00 am ET
Globe Newswire
March 21, 2023
5:20 pm ET
MarketWatch
2:00 am ET
Globe Newswire
1:59 am ET
Globe Newswire
March 20, 2023
5:20 pm ET
MarketWatch
March 18, 2023
10:00 am ET
Globe Newswire
10:00 am ET
Globe Newswire
March 17, 2023
5:20 pm ET
MarketWatch
March 16, 2023
5:21 pm ET
MarketWatch
March 15, 2023
5:21 pm ET
MarketWatch
March 14, 2023
10:56 pm ET
PR Newswire
9:30 pm ET
Globe Newswire
8:38 pm ET
MarketWatch
March 13, 2023
5:22 pm ET
MarketWatch
March 10, 2023
5:21 pm ET
MarketWatch
March 09, 2023
5:22 pm ET
MarketWatch
March 08, 2023
5:21 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.